Specialty Pharmacy

Blincyto is currently the only FDA-approved bispecific CD19-directed CD3 T cell engager immunotherapy available for the treatment of Philadelphia chromosome-negative relapsed or refractory B-cell precursor ALL.

Researchers examine acceptance rates and factors predicting doctor acceptance of pharmacist recommendations within a Medicare Advantage Plan.

BioMarin's AAV 5 factor VIII vector restores FVIII plasma concentrations, which are essential for creating blood clots in hemophilia A patients.

Researchers examine the risk of cancer recurrence among inflammatory bowel disease patients who take anti-TNF therapy.

Children of mothers who took atazanavir showed slightly decreased scores on language and social-emotional development.

Durvalumab and tremelimumab was active in patients with or without tumor expression of PD-L1 in NSCLC.

Telehealth offers a support system for patients with specific chronic illnesses prone to exacerbations and remissions, such as COPD.

Monitoring tool can help fight fraud, safeguard taxpayer dollars, and protect beneficiaries.

Nanoparticles acting as cancer drug delivery vehicles show promise in eliminating tumors.

High cost infused cancer drugs are packaged containing quantities larger than needed to treat patients.

Improvements seek to promote continuity in the Marketplace with a goal of ensuring that health care coverage is accessible and affordable to consumers.

Odefsey can be used as a replacement for antiretroviral therapy in HIV-positive patients who are virologically-suppressed.

Odefsey is the smallest single tablet regimen to treat patients 12-years-old and above infected with HIV.

This case is the first reported failure for pre-exposure prophylaxis to stop HIV infection.

Protein regulator may lead to new multiple sclerosis treatments.

Zepatier can be used with or without ribavirin and does not require interferon.

Adherence patterns and other risk factors predict increased utilization of acute care by outpatients with cancer pain.

Controversy swirls around the naming protocol for biosimilars among drug manufacturers and the FDA.

Research addresses whether the prior authorization process creates a barrier to timely and effective care for hepatitis C.

Nearly 1 of 4 initial requests for Harvoni were denied in a recent study of hepatitis C drug coverage.

NASP addresses what defines a specialty pharmacy and specialty medications.

Comprehensive medication management programs may improve drug adherence across multiple chronic conditions.

Men diagnosed with cancer under age 25 far less likely to have children and more likely to take infertility drugs.

Charlie Sheen's announcement that he is HIV-positive may lead to a new era of HIV preventative efforts.

Several chemotherapy agents have been investigated for neoadjuvant use in HER2-positive breast cancer.

Less than half of adolescents and young adults who survive Hodgkin lymphoma receive recommended services within the first year after treatment.

Sites and apps such as Grindr, Manhunt, Scruff, Adam4Adam, and Craigslist may be linked with higher STD incidences.

Zepatier is approved for the treatment of patients with chronic hepatitis C virus genotypes 1 and 4.